These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 27661106)
1. TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells. Orlandella FM; Di Maro G; Ugolini C; Basolo F; Salvatore G Oncotarget; 2016 Oct; 7(43):70575-70588. PubMed ID: 27661106 [TBL] [Abstract][Full Text] [Related]
2. Identification of targets of Twist1 transcription factor in thyroid cancer cells. Di Maro G; Orlandella FM; Bencivenga TC; Salerno P; Ugolini C; Basolo F; Maestro R; Salvatore G J Clin Endocrinol Metab; 2014 Sep; 99(9):E1617-26. PubMed ID: 24848707 [TBL] [Abstract][Full Text] [Related]
3. The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein. Mariniello RM; Orlandella FM; Stefano AE; Iervolino PLC; Smaldone G; Luciano N; Cervone N; Munciguerra F; Esposito S; Mirabelli P; Salvatore G Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973107 [TBL] [Abstract][Full Text] [Related]
4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
5. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma. Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126 [TBL] [Abstract][Full Text] [Related]
6. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway. Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303 [TBL] [Abstract][Full Text] [Related]
7. TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype. Salerno P; Garcia-Rostan G; Piccinin S; Bencivenga TC; Di Maro G; Doglioni C; Basolo F; Maestro R; Fusco A; Santoro M; Salvatore G J Clin Endocrinol Metab; 2011 May; 96(5):E772-81. PubMed ID: 21389145 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma. Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer. Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043 [TBL] [Abstract][Full Text] [Related]
11. MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1. Zhang W; Ji W; Zhao X BMC Cancer; 2019 Nov; 19(1):1093. PubMed ID: 31718618 [TBL] [Abstract][Full Text] [Related]
12. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway. Ma Y; Qin H; Cui Y Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
15. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD. Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells. Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257 [TBL] [Abstract][Full Text] [Related]
17. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer. Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531 [TBL] [Abstract][Full Text] [Related]
18. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma. Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328 [TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-625-3p promotes the proliferation, migration and invasion of thyroid cancer cells by up-regulating astrocyte elevated gene 1. Fang L; Kong D; Xu W Biomed Pharmacother; 2018 Jun; 102():203-211. PubMed ID: 29558717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]